Elicio Therapeutics Inc.

NASDAQ:ELTX 4:00:00 PM EDT

9.25

+0.03 (+0.32%)

Elicio Therapeutics Inc. Stock, NASDAQ:ELTX

451 D Street, 5th floor, Suite 501, Boston, Massachusetts 02210

United States of America

Phone: +1.857.209.0050

Number of Employees: 32

http://www.elicio.com

Description

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.